Bardin Hill Management Partners’s Amedisys AMED Stock Holding History

Bardin Hill Management Partners’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22,049	Closed	-$2.17M	–	8
2025 Q2	$2.17M	Buy	+22,049	New	+$2.09M	1.28%	16
2024 Q4	–	Sell	-124,342	Closed	-$12M	–	35
2024 Q3	$12M	Buy	124,342 +3,871	+3%	+$378K	5.59%	4
2024 Q2	$11.1M	Buy	120,471 +21,330	+22%	+$1.98M	4.49%	4
2024 Q1	$9.14M	Buy	99,141 +5,001	+5%	+$469K	3.81%	10
2023 Q4	$8.95M	Buy	94,140 +13,217	+16%	+$1.23M	3.81%	11
2023 Q3	$7.56M	Buy	80,923 +63,446	+363%	+$5.86M	2.43%	12
2023 Q2	$1.6M	Buy	+17,477	New	+$1.43M	0.41%	36

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bardin Hill Management Partners's AMED Position: Q3 2025 in Review

Bardin Hill Management Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 22,049 shares — an estimated $2.17M sold.

Bardin Hill Management Partners first reported a position in AMED in Q2 2023 and held it in 7 quarters. The position peaked at $12M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Bardin Hill Management Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Bardin Hill Management Partners sold 22,049 Amedisys shares in Q3 2025, an estimated $2.17M.
Bardin Hill Management Partners first reported a position in Amedisys in Q2 2023 and held it in 7 quarters.
Bardin Hill Management Partners's Amedisys position peaked at $12M in Q3 2024.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Bardin Hill Management Partners's 13F filing for Q3 2025, filed 12 Nov 2025.